We provide ENTREPRENEURS with the RESOURCES they need to BUILD and GROW a SUCCESSFUL company

All You Need to Succeed

Do you have a need to succeed? Join our community of entrepreneurs at Milwaukee’s largest business incubator.

The Technology Innovation Center is the largest and longest-running business incubator in the Greater Milwaukee Area with a proven track record of over 30 years.  With the perfect location at the Zoo Interchange, our community of entrepreneurs have the environment, support, and resources they need to build and grow a successful company.

Since 1993, more than 247 startups, growth companies, entrepreneurs, and non-profits have called us home. Our office and lab space are ideal for businesses specializing in bioscience, information technology and software development, venture investment, research, and more!


Membership Benefits

Membership benefits include affordable space, conference rooms, classrooms, copy and print room, 24/7 secure access, in-house resources, business coaching and mentoring, a resource directory, and financial assistance through loans and investor introductions.

Business Coaching & mentorship

24/7 Secure access

professional business address

Mail Management

Website Listing & company promotion

Community & Networking

available space

The Technology Innovation Center provides  80,000 square-feet of prime lab, light manufacturing, and office space with high-bandwidth internet connectivity, ample-three phase high voltage power, and high ceiling loading dock.

Lab space

20,000 square-feet of wet laboratories, supported by a core services facility with autoclave/sterilizer, endotoxin-free water, DI water, ice machine, glassware washer & dark room.

Small Office Space

50,000 square feet of office space of varying sizes. The smaller offices are ideal for professionals, accountants, lawyers, etc.

Large Office Space

50,000 square feet of office space of varying sizes. The larger office space is ideal for administrative offices, IT companies, software and application development.

Shared space

10,000 square-feet of recently renovated common areas, light manufacturing space and office suites, with two board rooms, two conference rooms and two classroom facilities with the latest AV technology.

Conference rooms


Copy & Print Center

Financial Assistance 

Micro Loan Program

The Technology Innovation Center micro loan program is available to its clients and tenants. Research development funds and grants are also available to entrepreneurs in the building. Contact the office for more information.

Investor Introductions

Introductions to angel and venture investors. Angel investors are generally high net worth individuals who invest capital in startups in exchange for equity. Venture capitalists are part of private firms with investment funds.

Preparation to Raise Capital

Preparation to raise capital involves conducting analysis, determining how much funding and its purpose, preparing your pitch and presentation, and refining as you progress.

success stories 

Entrepreneur Builds Niche Business on Technology Transfer from Medical College

Entrepreneur Builds Niche Business on Technology Transfer from Medical College

Richard Stevens’ love for science began in an unlikely way. As publication editor for various health care and scientific organizations, Stevens never imagined his degree in journalism from Ohio University would lead to him owning a medical device company. In fact, he’s created two successful companies based on technology transfer from academia.


Andy Nunemaker to join ‘Investor Hall of Fame’ at Wisconsin Early Stage Symposium in Madison

Andy Nunemaker, who has been an active member of Milwaukee’s Golden Angels Investors for more than 20 years, built and led companies and created a legacy of community service, will be inducted into the Wisconsin Technology Council’s “George Mosher Memorial Investor Hall of Fame” during the Nov. 8-9 Wisconsin Early Stage Symposium. Nunemaker is currently CEO of Groupware Technologies, a healthcare software company in the care management market.

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders and refractory epilepsy, today announced positive results of the qEEG (Quantitative Electroencephalogram) data in Cohort 4 of its first-in-human Phase 1 study of its lead compound, BMB-101.

Join our exceptional community of entrepreneurs, startups, & non-profits.